University of Ioannina
Άμεσες και απώτερες επιπτώσεις που παρατηρούνται σε ασθενείς με βαλβιδική ανεπάρκεια ή παραβαλβιδική διαφυγή μετά από διαδερμική εμφύτευση αορτικής βαλβίδας
Abstract
dc:descriptionIntroduction: The Transcatheter Aortic Valve Implantation (TAVI) is an adequately documented treatment option for patients with severe aortic valve stenosis. Its current indications are not limited to patients who are characterized as inoperable or high risk, but have also been extended to include intermediate surgical risk patients, based on strong recent research evidence, which confirms the safety and efficacy of the operation. Outcomes such as the degree of the regurgitation of the aortic and mitral valve and changes in the left ventricular ejection fraction (EF) have been studied in terms of frequency and factors influencing it. However, there is a relevant lack of bibliographic data regarding the demographic and clinical parameters that may be associated with the outcomes in patients undergoing TAVI. Purpose: To estimate the changes regarding the degree of the aortic and mitral valve regurgitation, as well as the EF, within the first 12 months after the operation, and toinvestigate the factors that affect these outcomes. Also, we aimed to identify the predictors of outcomes, such as intensive care unit (ICU) and in-hospital length of stay (LOS), duration ofpostoperative intubation and in-hospital mortality, after TAVI procedures. Materials and methods: According to our study design, we initially intended to collect data both from the 2nd Cardiac-Surgery Department of the University Hospital of Ioannina – Greece and the Cardiac-Surgery Center of Liverpool – UK. However, the different types of TAVI valves do not allow us to include the patients of the University Hospital of Ioannina in our study sample, aiming to secure the homogeneity of the collected data and to avoid bias. This was a retrospective study, with a total sample of 162 patients subjected to TAVI, either via transfemoral, or transapical approach in a Cardiothoracic Center of the United Kingdom, during a five-year period (September 2008 – October 2013). The data collection was performed in November 2014 through the electronic database of the Cardiothoracic Center. The prevalence and temporal changes in the degree of the aortic and mitral valve regurgitation were investigated. We also investigated the values of the EF within 12 months ofTAVI and specifically pre-operatively, directly postoperatively, 6 and 12 months after the invasive procedure. In addition, the factors affecting the above mentioned outcomes were also investigated. In all patients, the bioprosthetic valve Sapiens - Edwards XT (Edwards Lifesciences Inc., Irvine, California) was implanted. The statistical analysis of the data was carried out with the IBM SPSS 21.0 package. Results: The sample consisted of women in 56%, while 53% of the patients underwent TAVI through transfemoral access. The average age of the participants was 81.8 (±7.6) years. Patients were characterized by a statistically significant increase in the degree of the aorticvalve regurgitation (P < 0,001), but this change was not clinically significant. Moreover, although no statistically significant changes occurred in the degree of mitral valve regurgitation and the EF within the first 12 months. Gender was the only parameter associated with these variables. Specifically, women were characterized by a significantly greater reduction in the degree of mitral valve regurgitation postoperatively (P =0.04), while men showed significantly greater improvement of the EF postoperatively (P = 0.02). The efficacy of TAVI appeared to be particularly high, given the absence or mild aortic valve regurgitation directly postoperatively in the majority of the patients (91%). By using a multivariate analysis we found that any postoperative bleeding [odds ratio (OR) 2.71, 95% confidence interval (CI) 1.41-5.24] was the independent predictor of prolonged ICU-LOS, while older age (OR 1.11, 95% CI 1.05-1.17) and transapical TAVI (OR 4.11, 95% CI 1.94-8.71) were the predictors of prolonged in-hospital LOS. Additionally, patients treated with oral inotropic agents, preoperatively (OR 5.77, 95% CI 2.21-15.01), non-diabetics(OR 3.07, 95% CI 1.12-8.42) and those with any postoperative bleeding (OR 3.53, 95% CI 1.68-7.43) had a significantly greaterprobability in remaining intubated postoperatively. Finally, the multivariate analysis did not reveal any predictor of in-hospital mortality. Conclusions: The absence of negative outcomes in patients undergoing TAVI, concerning the degree of the aortic and mitral valve regurgitation, and the values of EF within 12 months from the intervention is an indicator of the high efficacy of these invasive procedures. Sex seems to affect ultrasonographic parameters, such as the degree of change in mitral valve regurgitation, but also the EF. Additionally, parameters such as postoperative bleeding, the older age, the adsence of diabetes mellitus and preoperative oral inotropic support seem tohave statistically significant association with poor TAVI patient outcomes. This knowledge could contribute to the early identification of higher risk patients which might present negative outcomes after TAVI. Given the limitations of this study, further research is required based on studies with a larger sample size, perspective, randomized design, and data acquisition by more cardiac centers.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Patris, Vasileios-Pantelis
- Πάτρης, Βασίλειος-Παντελής
Subjects
dc:subject × 18- Ανεπάρκεια αορτικής βαλβίδας
- Ανεπάρκεια μιτροειδούς βαλβίδας
- Διακαθετηριακή εμφύτευση αορτικής βαλβίδας
- Εκβάσεις
- Κλάσμα εξώθησης αριστεράς κοιλίας
- Παραβαλβιδική διαφυγή
- Aortic valve deficiency
- Mitral valve regurgitation
- Transcatheter aortic valve implantation
- Outcomes
- Left ventricular ejection fraction
- Paravalvular leak
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Άλλες Ιατρικές Επιστήμες
- Medical and Health Sciences
- Health Sciences
- Other Medical Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46999